Key result
At a median age of 18 months, 48.3% of infants with prior enterovirus CNS infection and 20% with parechovirus CNS infection presented some developmental concern in the ASQ-3 test.
Why the study?
Enteroviruses and human parechoviruses cause central nervous system infections in young infants and are implicated in neurodevelopmental delay, but limited data are available.
Observational (n=48)
Yes
Infants with EV and HPeV CNS infections without encephalitis have a notable rate of medium-term neurodevelopmental concerns, particularly in communication for EV infections.
Answers are grounded in this paper and cite their sources.
Suggests developmental surveillance after infant EV/HPeV CNS infection; leaves open need for prospective studies before changing practice.
Enteroviruses (EVs) and human parechoviruses (HPeVs) are a major cause of central nervous system (CNS) infection in young infants. They have been implicated in neurodevelopmental delay, however limited data are available. The aim of this study is to describe the clinical outcome of young infants and to assess and compare the medium-term neurodevelopment following CNS infections caused by EV and HPeV. A multicentre observational ambispective study was conducted between May 2013 and March 2018. Children under 3 months of age with EV or HPeV CNS infection excluding encephalitis were included. Infants were contacted 1 year after the acute infection and their neurological development was evaluated using the Ages and Stages Questionnaire-3 (ASQ-3). If any area assessed was abnormal during the first round of tests, a second round was completed 6 to 12 months later. Forty-eight young infants with EV and HPeV CNS infection were identified: 33 (68.8%) were positive for EV and 15 (31.3%) for HPeV. At first assessment 14 out of 29 EV (48.3%) and 3 out of 15 HPeV (20%) positive cases presented some developmental concern in the ASQ-3 test. EV-positive infants showed mild and moderate alteration in all domains analyzed and HPeV-positive infants showed mild alterations only in gross and fine motor domains. Significant alterations in communication were observed in EV-positive but not in HPeV-positive infants (31 vs. 0%,p= 0.016). At second assessment 4 out of 13 EV-positive patients (30.8%) showed mild to moderate concerns in communication and gross motor function domains and 3 out of 13 (23.1%) showed significant concern in fine motor function. Although CNS infections without associated encephalitis are generally assumed to be benign our study shows that at a median age of 18 months almost half of the EV-infected infants (48.3%) and 20% of HPeV-positive infants presented some developmental concern in the ASQ-3 test. We recommend monitor the neurological development of infants during the first years of life after HPeV CNS infection and especially after EV CNS infection, even in mild cases, for an early intervention and stimulation of psychomotor development if necessary.
No takes yet. Share an insight, caveat, or question.
Ceano-Vivas et al. (2021) conducted an observational in Enterovirus and Parechovirus Infections of the Central Nervous System (n=48). Enterovirus (EV) CNS infection vs. Parechovirus (HPeV) CNS infection was evaluated on Developmental concern in the ASQ-3 test at first assessment (p=0.068). At a median age of 18 months, 48.3% of infants with prior enterovirus CNS infection and 20% with parechovirus CNS infection presented some developmental concern in the ASQ-3 test.
Synapse has enriched 10 related papers. Consider them for comparative context: